Oncology & Cancer

Targeting pancreatic cancer drug resistance

Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%. Novel therapies are urgently needed, as conventional and targeted approaches have not been successful and ...

Medical research

Investigational diabetes drug may have fewer side effects

Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side effects, researchers ...

Health

New mouthwash may render cavities a thing of the past

(Medical Xpress) -- A new mouthwash developed by a microbiologist at the UCLA School of Dentistry is highly successful in targeting the harmful Streptococcus mutans bacteria that is the principal cause tooth decay and cavities.

Medications

Clinical trial investigates new oral treatment for COVID-19

An exploratory clinical trial (SIGMA4COVID) through a collaboration between Catalonia and Galicia, the results of which are published in the Journal of Infection, suggests the usefulness of a drug, E-52862, for the treatment ...

page 2 from 12